Literature DB >> 31433489

The ImPreSS Trial: Implementation of Point-of-Care Pharmacogenomic Decision Support in Perioperative Care.

Tien M Truong1,2, Jeffrey Apfelbaum3, Sajid Shahul3, Magdalena Anitescu3, Keith Danahey2,4, Randall W Knoebel5, David Liebovitz6, Theodore Karrison7, Xander M R van Wijk1,2,8, Kiang-Teck J Yeo1,2,8, David Meltzer6, Mark J Ratain1,2,6, Peter H O'Donnell1,2,6.   

Abstract

Entities:  

Mesh:

Year:  2019        PMID: 31433489      PMCID: PMC7214100          DOI: 10.1002/cpt.1567

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

1.  Clinical pharmacogenetics implementation: approaches, successes, and challenges.

Authors:  Kristin W Weitzel; Amanda R Elsey; Taimour Y Langaee; Benjamin Burkley; David R Nessl; Aniwaa Owusu Obeng; Benjamin J Staley; Hui-Jia Dong; Robert W Allan; J Felix Liu; Rhonda M Cooper-Dehoff; R David Anderson; Michael Conlon; Michael J Clare-Salzler; David R Nelson; Julie A Johnson
Journal:  Am J Med Genet C Semin Med Genet       Date:  2014-03-10       Impact factor: 3.908

2.  Simplifying the use of pharmacogenomics in clinical practice: Building the genomic prescribing system.

Authors:  Keith Danahey; Brittany A Borden; Brian Furner; Patrick Yukman; Sheena Hussain; Donald Saner; Samuel L Volchenboum; Mark J Ratain; Peter H O'Donnell
Journal:  J Biomed Inform       Date:  2017-09-28       Impact factor: 6.317

3.  The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.

Authors:  J A Luzum; R E Pakyz; A R Elsey; C E Haidar; J F Peterson; M Whirl-Carrillo; S K Handelman; K Palmer; J M Pulley; M Beller; J S Schildcrout; J R Field; K W Weitzel; R M Cooper-DeHoff; L H Cavallari; P H O'Donnell; R B Altman; N Pereira; M J Ratain; D M Roden; P J Embi; W Sadee; T E Klein; J A Johnson; M V Relling; L Wang; R M Weinshilboum; A R Shuldiner; R R Freimuth
Journal:  Clin Pharmacol Ther       Date:  2017-06-09       Impact factor: 6.875

4.  Establishment of CYP2D6 reference samples by multiple validated genotyping platforms.

Authors:  H Fang; X Liu; J Ramírez; N Choudhury; M Kubo; H K Im; A Konkashbaev; N J Cox; M J Ratain; Y Nakamura; P H O'Donnell
Journal:  Pharmacogenomics J       Date:  2014-07-01       Impact factor: 3.550

  4 in total
  9 in total

Review 1.  Clinical implementation of drug metabolizing gene-based therapeutic interventions worldwide.

Authors:  Evangelia Eirini Tsermpini; Zeina N Al-Mahayri; Bassam R Ali; George P Patrinos
Journal:  Hum Genet       Date:  2021-10-01       Impact factor: 4.132

2.  Appraisal and development of evidence-based clinical decision support to enable perioperative pharmacogenomic application.

Authors:  Brittany A Borden; Ellie H Jhun; Keith Danahey; Emily Schierer; Jeffrey L Apfelbaum; Magdalena Anitescu; Randall Knoebel; Sajid Shahul; Tien M Truong; Mark J Ratain; Peter H O'Donnell
Journal:  Pharmacogenomics J       Date:  2021-08-10       Impact factor: 3.245

Review 3.  Modern developments in germline pharmacogenomics for oncology prescribing.

Authors:  Natalie M Reizine; Peter H O'Donnell
Journal:  CA Cancer J Clin       Date:  2022-03-18       Impact factor: 286.130

4.  Anesthesia providers as stakeholders to adoption of pharmacogenomic information in perioperative care.

Authors:  Tien M Truong; Jeffrey L Apfelbaum; Emily Schierer; Keith Danahey; Brittany A Borden; Theodore Karrison; Sajid Shahul; Magdalena Anitescu; Rebecca Gerlach; Randall W Knoebel; David O Meltzer; Mark J Ratain; Peter H O'Donnell
Journal:  Pharmacogenet Genomics       Date:  2022-04-01       Impact factor: 2.089

5.  Validation of a Large Custom-Designed Pharmacogenomics Panel on an Array Genotyping Platform.

Authors:  Nga Yeung Tang; Xun Pei; David George; Larry House; Keith Danahey; Elizabeth Lipschultz; Mark J Ratain; Peter H O'Donnell; Kiang-Teck J Yeo; Xander M R van Wijk
Journal:  J Appl Lab Med       Date:  2021-11-01

6.  Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.

Authors:  J Kevin Hicks; Nihal El Rouby; Henry H Ong; Jonathan S Schildcrout; Laura B Ramsey; Yaping Shi; Leigh Anne Tang; Christina L Aquilante; Amber L Beitelshees; Kathryn V Blake; James J Cimino; Brittney H Davis; Philip E Empey; David P Kao; Daniel L Lemkin; Nita A Limdi; Gloria P Lipori; Marc B Rosenman; Todd C Skaar; Evgenia Teal; Sony Tuteja; Laura K Wiley; Helen Williams; Almut G Winterstein; Sara L Van Driest; Larisa H Cavallari; Josh F Peterson
Journal:  Clin Pharmacol Ther       Date:  2021-02-16       Impact factor: 6.903

7.  Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial.

Authors:  Natalie Reizine; Everett E Vokes; Ping Liu; Tien M Truong; Rita Nanda; Gini F Fleming; Daniel V T Catenacci; Alexander T Pearson; Sandeep Parsad; Keith Danahey; Xander M R van Wijk; Kiang-Teck J Yeo; Mark J Ratain; Peter H O'Donnell
Journal:  Ther Adv Med Oncol       Date:  2020-12-17       Impact factor: 8.168

8.  Characterizing pharmacogenetic programs using the consolidated framework for implementation research: A structured scoping review.

Authors:  John H McDermott; Stuart Wright; Videha Sharma; William G Newman; Katherine Payne; Paul Wilson
Journal:  Front Med (Lausanne)       Date:  2022-08-18

9.  A hybrid implementation-effectiveness randomized trial of CYP2D6-guided postoperative pain management.

Authors:  Julie A Johnson; Larisa H Cavallari; Cameron D Thomas; Hari K Parvataneni; Chancellor F Gray; Justin T Deen; Hernan A Prieto; Luis F Pulido; Amanda R Elsey; Erica N Elwood; Petr Starostik; Yan Gong; Roger B Fillingim
Journal:  Genet Med       Date:  2021-01-08       Impact factor: 8.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.